Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Re: Funding package to move to production

19 Apr 2022 07:00

RNS Number : 5587I
Bluebird Merchant Ventures Limited
19 April 2022
 

Bluebird Merchant Ventures Ltd

("Company" or "Bluebird")

Clarification re: Funding package to accelerate move to production

Bluebird Merchant Ventures (EPIC: BMV), the Korean focused gold development group is pleased to provide a clarification to the announcement that was made on 12 April 2022. The funding package that was announced is anticipated to provide the Company with at least USD 3.1 million of funding once fully completed.

The Company stated that "13,003,268 shares have been issued at an average price of 2 pence per share and warrants over 25,280,000 shares with an exercise price of 2.5 pence per share and three-year."

The correct number is 12,003,268 shares and these have been issued at an average price of 2 pence per share. New warrants over 15,280,000 shares with an exercise price of 2.5 pence per share and a three-year life have been issued and existing warrants over 9,464,916 shares expiring on 12 September 2024 have also been repriced to 2.5 pence per share. The existing loan of £250,000 remains in place with the Company and management intends to repay this in the short term.

The Company will make application for the shares to be admitted to trading which is now expected on or around 26 April 2022. Upon Admission there will be 634,319,056 shares in issue.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

Enquiries:

Bluebird Merchant Ventures Ltd

Jonathan Morley-Kirk, Non-Executive Chairman jmk@bluebirdmv.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURGPUGACUPPUAB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.